| For: | Wang JL, Sun YL, Kang Z, Zhang SK, Yu CX, Zhang W, Xie H, Lin HL. Anti-phospholipase A2 receptor-associated membranous nephropathy with human immunodeficiency virus infection treated with telitacicept: A case report. World J Clin Cases 2023; 11(22): 5309-5315 [PMID: 37621578 DOI: 10.12998/wjcc.v11.i22.5309] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i22/5309.htm |
| Number | Citing Articles |
| 1 |
Qiuyu Fan, Hongyan Ji, Ya Liu, Chao Jia, Liang Zou, Huiqin Yang. Refractory lupus hepatitis successfully treated with telitacicept who failed to belimumab: A case report and literature review. Lupus 2024; 33(4): 414 doi: 10.1177/09612033241233021
|
| 2 |
Fang Lu, Si Chen, Honglei Guo, Qing Li, Lin Wu, Ying Pan, Yangfan Wu, Hua Shu, Simeng Liu, Bo Zhang, Huijuan Mao, Changying Xing, Hongwei Liang, Suyan Duan, Yanggang Yuan. Exploring immunological alterations of B cells in peripheral immunity via single-cell RNA sequencing: insights into primary membranous nephropathy. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1622395
|
| 3 |
|
| 4 |
Xuefei Li, Yao Fu, HaiQin Yin, Huiling Zhu. Successful treatment of refractory systemic lupus erythematosus-associated immune thrombocytopenia with drug-induced liver injury with telitacicept: a case report and review. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1473190
|
| 5 |
Yang Yang, Kaiqi Cheng, Gaosi Xu. Novel approaches to primary membranous nephropathy: Beyond the KDIGO guidelines. European Journal of Pharmacology 2024; 982: 176928 doi: 10.1016/j.ejphar.2024.176928
|
| 6 |
Shucheng Chen, Yiqi Huang, Zhongjie Qu. Telitacicept monotherapy for refractory idiopathic membranous nephropathy: a case report and literature review. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1571616
|
